Related Experiment Videos

Cardiac troponins: utility in renal insufficiency and end-stage renal disease

Suzanne Watnick1, Mark A Perazella

  • 1Department of Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA.

Seminars in Dialysis
|March 5, 2002
PubMed

Insights

Cardiac troponin I (cTnI) shows excellent specificity for diagnosing acute coronary syndromes in patients with renal dysfunction. However, it remains an imperfect marker, necessitating further research for improved diagnostic accuracy in this population.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker Research

Background:

  • Current serum markers for cardiac injury in renal insufficiency have limited accuracy.
  • Cardiac troponins (cTnI, cTnT) are established myocardial injury markers in non-renal failure patients.
  • Assessing troponin utility in renal dysfunction is crucial for accurate diagnosis.

Observation:

  • Cardiac troponin I (cTnI) demonstrates high specificity in patients with impaired kidney function.
  • Existing data suggests cTnI is a valuable, though not perfect, indicator of myocardial injury in this cohort.
  • Further studies are needed to fully elucidate cTnI's role in diagnosing acute coronary syndromes.

Findings:

  • Cardiac troponin I exhibits excellent specificity for acute myocardial infarction in patients with renal dysfunction.
  • Cardiac troponin T (cTnT) sensitivity and specificity in renal dysfunction require further investigation.
  • cTnI is a useful, but imperfect, serum marker for acute coronary syndrome in patients with renal impairment.

Implications:

  • cTnI can aid in diagnosing acute coronary syndromes in patients with renal insufficiency.
  • The imperfect nature of cTnI necessitates careful interpretation and consideration of other clinical factors.
  • Continued research is vital to refine the diagnostic utility of cardiac troponins in renal dysfunction.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.